Management of Hypertrophy of Nasal Turbinates

A Comparative Clinical Study To Evaluate The Efficacy Of Apamarga Kshara And Arka Kshara In Nasapratinaha W.S.R To Hypertrophy Of Nasal Turbinates

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079071

Enrollment

110

Registered

2025-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J010- Acute maxillary sinusitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged above 16 years and below 60 years Patients diagnosed for Nasapratinaha based on clinical features of Nasapratinaha (Hypertrophy of Turbinates) with irrespective of gender caste religion socio economic status and chronicity. Patient were selected those are willing to participate.

Exclusion criteria

Exclusion criteria: Patients with other systemic diseases. Patients with epistaxis. Patients unfit for Kshara Karma. Nasal abstruction other than Hypertrophy of Turbinates.

Design outcomes

Primary

Measure	Time frame
The qualities of medicine Arka kshara leads to Reducing Nasal obstruction Sneezing of Nasanaha so size and shape of HHypertropy of turbinates is reducedTimepoint: 21 days	—

Secondary

Measure	Time frame
The medicine Apamarga kshara leads to Reducing Nasal obstruction Sneezing of Nasanaha so size & shape of HHypertropy of turbinates is reduced & all signs & symptoms are relivedTimepoint: 21 dyas	—

Countries

India

Contacts

Public ContactDr Vijayakumar Nayak

RKM AYURVED MEDICAL COLLEGE AND HOSPITAL VIJAYAPUR KARNATAKA INDIA

vinu2966@gmail.com9986303076

Outcome results